Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

     
Available items only
Print Material
Corporate Author United States. Government Accountability Office, author.

Title Generic drugs : stakeholders views on improving FDA's information on patents : report to congressional committees / United States Government Accountability Office.

Publication Info. Washington, DC : United States Government Accountability Office, 2023.

Copies

Description 1 online resource (ii, 41 pages) : color illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Note "March 2023."
"GAO-23-105477."
In scope of the U.S. Government Publishing Office Catalog and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
Bibliography Includes bibliographical references.
Note Description based on online resource; title from PDF title page (GAO, viewed July 18, 2023).
Subject United States. Food and Drug Administration -- Rules and practice.
United States. Food and Drug Administration
Generic drugs -- United States -- Patents.
Generic drugs -- Government policy -- United States.
Generic drugs -- Development -- United States.
Médicaments génériques -- États-Unis -- Brevets d'invention.
Médicaments génériques -- Politique gouvernementale -- États-Unis.
Médicaments génériques -- Développement -- États-Unis.
Generic drugs
Generic drugs -- Government policy
United States
Genre/Form Patents
Rules
Added Title Generic drugs : stakeholders views on improving Food and Drug Administration's information on patents
Running Title GAO-23-105477 FDA information on drug patents
Gpo Item No. 0546-D (online)
Sudoc No. GA 1.13:GAO-23-105477

 
    
Available items only